(NASDAQ:WGS) NEW YORK, Aug. 31, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially...
Related Questions
What is the likely timeline and potential financial exposure from the securities class action investigation?
How could this legal development affect GeneDx's valuation metrics and short‑term price volatility?
What is the market’s perception of the risk compared to peers and how might institutional investors adjust their positions?